A summary of the new GINA strategy: a roadmap to asthma control
Top Cited Papers
Open Access
- 23 July 2015
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 46 (3), 622-639
- https://doi.org/10.1183/13993003.00853-2015
Abstract
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence.This article provides a summary of key changes in the GINA report, and their rationale. The changes include a revised asthma definition; tools for assessing symptom control and risk factors for adverse outcomes; expanded indications for inhaled corticosteroid therapy; a framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues; optimisation of medication effectiveness by addressing inhaler technique and adherence; revised recommendations about written asthma action plans; diagnosis and initial treatment of the asthma−chronic obstructive pulmonary disease overlap syndrome; diagnosis in wheezing pre-school children; and updated strategies for adaptation and implementation of GINA recommendations.Keywords
This publication has 103 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- Global asthma prevalence in adults: findings from the cross-sectional world health surveyBMC Public Health, 2012
- Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherenceJournal of Allergy and Clinical Immunology, 2011
- Daily or Intermittent Budesonide in Preschool Children with Recurrent WheezingNew England Journal of Medicine, 2011
- Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in AsthmaNew England Journal of Medicine, 2011
- Shared Treatment Decision Making Improves Adherence and Outcomes in Poorly Controlled AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezingJournal of Allergy and Clinical Immunology, 2008
- Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhoodThorax, 2008
- Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 productionProceedings of the National Academy of Sciences of the United States of America, 2008
- Proportional classifications of COPD phenotypesThorax, 2008